p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes

International Immunology

Volumn 9, Issue 9, 1997, Pages 1271-1279

  Poggi, Alessandro ^a   Tomasello, Elena ^a   Revello, Valentino ^a   Nanni, Luca ^b   Costa, Paola ^a   Moretta, Lorenzo ^a,b  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Activating NKR; HLA class I; NK cells; Regulation; TCR activation

Indexed keywords

CALCIUM ION; CD16 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CELL RECEPTOR; GAMMA INTERFERON; HERMES ANTIGEN; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; PROTEIN P40; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CLONE; CELL MATURATION; CONTROLLED STUDY; CROSS LINKING; CYTOLYSIS; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NORMAL HUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TARGET CELL;

CALCIUM; CYTOTOXICITY, IMMUNOLOGIC; DNA-BINDING PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030873727     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.9.1271     Document Type: Article

References (29)

1. Muta, T., Kurosaki, Z., Misulovin, M., Sanchez, M., Nussenzweig, M. C. and Ravetch, J. V. 1994. A 13-aminoacid motif in the cytoplasmic domain of FC gamma RIIB modulates B-cell receptor signaling. Nature 368:70.
2. D'Ambrosio, D., Hippen, K. L., Minskoff, S. A., Mellman, I., Pani, G., Simonovitch, K. A. and Cambier, J. C. 1995. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcgammaRIIB1. Science 268:293.
3. Moretta, A., Bottino, C., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C. and Moretta, L. 1996. Receptors for HLA-I molecules in human Natural Killer cells. Annu. Rev. Immunol. 14:619.
4. Lanier, L. L. and Phillips, J. H. 1996. Inhibitory MHC class I receptors on NK cells and T cells, Immunol Today 17:86.
5. Litwin, V., Gumperz, J. E., Parham, P., Phillips, J. H. and Lanier, L. L. 1994. NKB1: a natural killer cell receptor involved in the regulation of polymorphic HLA-B molecules. J. Exp. Med. 180:537.
6. Vitale, M., Sivori, S., Pende, D., Augugliaro, R., Di Donato, C., Amoroso, A., Malnati, M., Bottino, C., Moretta, L. and Moretta, A. 1996. Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. Proc. Natl Acad. Sci. USA 93:1453.
7. Dohring, C., Scheidegger, D., Samaridis, J., Cella, M. and Colonna, M. 1996. A human killer inhibitory receptor specific for HLA-A. J. Immunol. 156:3098.
8. Pende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M., di Donato, C., Accame, L., Bottino, C., Moretta, A. and Moretta, L. 1996. The natural killer cell receptor specific for HLA-A allotypes. A novel member of the p58/p70 family of inhibitory receptors which is characterized by three Ig-like domains and is expressed as a 140kD disulphide-linked dimer. J. Exp. Med. 184:1.
9. Lopez-Botet, M. 1995. CD94 Cluster report: overwiev of the characterization of Kp43 NK-cell associated surface antigen. In Schlossman, S. F., Boumsell, L., Gilks, W., Harlan, J. H., Kishimoto, T., Morimoto, C., Ritz, J., Shaw, S., Silverstein, R., Springer, T., Tedder, T. F. and Todd, R. F., eds, Leucocyte Typing V, p. 1437. Oxford University Press, Oxford.
10. Moretta, A., Vitale, C., Sivori, S., Morelli, L., Pende, D. and Bottino, C. 1996. Molecular basis of NK cell recognition and function. Chem. Immunol. 64:77.
11. Phillips, J. H., Chang, C., Mattson, J., Gumperz, J, E., Parham, P. and Lanier, L. L. 1996. CD94 and a novel associated protein (CD94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B and HLA-C allotype. Immunity 5:163.
12. Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C. and Moretta, L. 1995. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182:875.
13. Pérez- Villar J. J., Melero, I., Rodriguez, A., Carretero, M., Aramburu, J., Sivori, S., Orengo, A. M., Moretta, A. and Lòpez-Botet, M. 1995. Funtional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J. Immunol. 154:5779.
14. Poggi, A.,Pella, N., Morelli, L, Spada, F., Revello, V, Sivori, S., Augugliaro, R., Moretta, L and Moretta, A. 1995. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Eur. J. Immunol. 25:369.
15. + natural killer cells. Role in cell activation and regulation of cytolytic function. J. Exp. Med. 71:695.
16. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK cell clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 172:1589.
17. + human 'natural killer' cells. Int. J. Cancer 44:727.
18. Zocchi, M. R., Vidal, M. and Poggi, A. 1993. Involvement of N-CAM molecule in the adhesion of human solid tumor cell line to endothelial cells. Exp. Cell. Res. 204:130.
19. Bottino, C., Tambussi, G., Ferrini, S., Ciccone, E., Mingari, M. C., Varese, P., Moretta, L. and Moretta, A. 1988. Two subset of human T lymphocytes expressing gamma-delta antigen receptor are identifiable by monoclonal anti-bodies directed to two distinct molecular forms of the receptor. J. Exp. Med. 168:491.
20. - lymphocytes to express their functional program(s). J. Exp. Med. 168:1.
21. Moretta, A., Poggi, A., Olive, D., Bottino, C., Pantaleo, G., Fortis, C. and Moretta, L. 1987. Selection of characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44 and T11): analysis of the functional relationship among different pathways of activation. Proc. Natl Acad. Sci. USA 84:1654.
22. Poggi, A., Pardi, R., Pella, N., Morelli, L., Spada, Sivori, S., Vitale, M., Revello, V, Moretta, A. and Moretta, L. 1993. CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal anti-bodies inhibit the calcium mobilization induced via LFA1 molecules, Eur. J. Immunol. 23:2454.
23. Moretta, A., Pantaleo, G., Moretta, L., Cerottini, J. C. and Mingari, M. C. 1983. Direct demonstration of the clonogenic poential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J. Exp. Med. 157:743.
24. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440.
25. Colotta, F., Bersani, L., Lazzarin, A., Poli, G., and Mantovani, A. 1985. Rapid killing of actinomycin D-treated tumor cells by human monocytes II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors. J. Immunol. 134:3524.
26. Ferrarini, M., Ferrero, E., Fortis, C., Poggi, A. and Zocchi, M. R. 1990. LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes. Br. J. Cancer. 62:754.
27. Thomas, M. L. 1989. The leukocyte common antigen family. Annu. Rev. Immunol. 7:339.
28. Newman, W., Fast, L. D. and Rose, L. M. 1983. Blockade of NK cell lysis is a property of monoclonal anti-bodies that bind to distinct regions of T-200. J. Immunol. 131:1742.
29. Seaman, W. E., Talal, N., Herzemberg, L. A. and Ledbetter, J. A. 1981. Surface antigens on mouse natural killer cells: use of monoclonal antibodies to inhibit or to enrich cytotoxic activity. J. Immunol. 127: 982.